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Abstract An increase in body mass due to oedema has
been previously described. The aim of this study was to
investigate a potential association between both fluid and
electrolyte intake and the formation of peripheral oedemas.
Fluid and electrolyte intakes and the changes in limb vol-
umes in 50 male 100-km ultra-marathoners were measured.
Pre- and post-race serum sodium concentration ([Na?]),
serum aldosterone concentration, serum copeptin concen-
tration, serum and urine osmolality and body mass were
determined. Fluid intake, renal function parameters and
urinary output, as well as the changes of volume in the
extremities, were measured. The changes of volume in the
limbs were measured using plethysmography. Serum [Na?]
increased by 1.6%; body mass decreased by 1.9 kg. Serum
copeptin and aldosterone concentrations were increased.
The change in serum copeptin concentration and the
change in serum [Na?] correlated positively; the change in
serum [Na?] and body mass correlated negatively. A mean
fluid intake of 0.58 L/h was positively related to running
speed and negatively to post-race serum [Na?]. Total fluid
intake was positively related to the changes in both arm and
lower leg volumes. Running speed was positively associ-
ated with the changes in arm and lower leg volumes; race
time was related to the changes in serum copeptin or
aldosterone concentrations. To conclude, fluid intake was
related to the changes in limb volumes, where athletes with
an increased fluid intake developed an increase in limb
volumes.
Keywords Electrolytes  Aldosterone  Vasopressin 
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Introduction
Exercise-associated hyponatremia (EAH) is a common and
severe electrolyte disorder in endurance athletes (Noakes
et al. 1990; Siegel et al. 2007; Speedy et al. 1999). EAH
was first described in the scientific literature in ultra-run-
ners in South Africa by Noakes et al. (1985) as serum or
plasma sodium concentration ([Na?]) \135 mmol/L dur-
ing or within 24 h post-race (Hew-Butler et al. 2005, 2008;
Kipps et al. 2011; Rosner and Kirven 2007; Siegel et al.
2007; Speedy et al. 1999). Athletes with EAH may present
symptoms, such as weakness, confusion, headache, nausea
or vomiting, increasing to complications such as enceph-
alopathy, seizures, pulmonary oedema, cerebral oedema
and death (Ayus et al. 2000; Hew-Butler et al. 2005;
Speedy et al. 2001). Alternatively, athletes with serum
[Na?] levels \135 mmol/L may be asymptomatic (Hew-
Butler et al. 2005, 2008; Knechtle et al. 2011a, b; Rosner
and Kirven 2007).
In runners, the prevalence of EAH varies widely from
0.3% in a 90-km race (Noakes et al. 1990) over 3% at the
2006 ‘Zurich Marathon’ (Mettler et al. 2008) to 12.5% in
the 2003 ‘London Marathon’ (Kipps et al. 2011) and 13%
in the 2002 ‘Boston Marathon’ (Almond et al. 2005). In
ultra-endurance athletes such as Ironman triathletes, a
prevalence of 18% EAH has been reported at the 1997
Communicated by Susan A. Ward.
A. Bracher  B. Knechtle  M. Gna¨dinger  J. Bu¨rge 
C. A. Ru¨st  T. Rosemann
Institute of General Practice and Health Services Research,
University of Zurich, Zurich, Switzerland
B. Knechtle (&)  P. Knechtle
Gesundheitszentrum St. Gallen, Vadianstrasse 26,
9001 St. Gallen, Switzerland
e-mail: beat.knechtle@hispeed.ch
123
Eur J Appl Physiol (2012) 112:991–1003
DOI 10.1007/s00421-011-2056-3
‘New Zealand Ironman’ (Speedy et al. 1999). These
prevalence rates of EAH were rather low considering a
very recent study on ultra-marathoners where Lebus et al.
(2010) reported, at the ‘Rio Del Lago 161 km endurance
run’ in 2008, an extremely high prevalence of EAH of
51.2%. In another ultra-marathon over 24 h, however, no
case of EAH was found (Knechtle et al. 2010a). In general,
prevalence of EAH was no higher in ultra-endurance ath-
letes (Knechtle et al. 2011a, b) when compared with
existing reports on marathoners and Ironman triathletes.
The reason of developing EAH is a behavioural condi-
tion such as overdrinking during an endurance performance
(Noakes et al. 2005; Noakes 2011). Studies showed that
when athletes were encouraged to limit their fluid intakes,
drinking only in response to thirst, there were no cases of
EAH (Noakes et al. 2004; Speedy et al. 2000b). The dif-
ference in prevalence of EAH such as an increasing num-
ber of cases of EAH in the United States (Lebus et al.
2010) as compared to a decreasing number of cases in
South Africa and in New Zealand (Noakes et al. 2005) as
well as in Europe (Knechtle et al. 2010a, 2011a, b) can be
explained by the fact that the sports drink industry could
promote in America its erroneous ‘science of hydration’ so
that athletes were overdrinking during an endurance per-
formance (Noakes 2010, 2011). In contrast to America,
South Africa and New Zealand did not spread the wrong
message about ‘science of hydration’, in these parts of the
world the scientist were able to spread the true message
across so athletes began to drink in accordance with the
dictates of thirst during exercise (Noakes 2010, 2011).
However, in the 161-km ultra-marathon from Lebus et al.
(2010), the runners lost 2.9% in body mass and 16.4% in
fat mass although 51.2% of the finishers developed EAH.
Nine finishers (22%) with post-race serum [Na?]
\135 mmol/L lost 3.5–8% in body mass and where
therefore not likely to be overhydrated. These findings
were in contrast to other studies that found EAH to be
relatively rare in subjects who lost [3% in body mass.
Presumably, the loss in body mass was associated with the
loss in fat mass as it has already been shown in ultra-
marathoners (Knechtle et al. 2011d).
Fluid overload can largely account for the development
of EAH, and a correlation between an increase in body
weight due to fluid overload and a decrease of serum [Na?]
was described in several studies (Irving et al. 1991; Mettler
et al. 2008; Noakes et al. 2005; Speedy et al. 1999). We
know that this form of behaviour is the only risk factor for
EAH since when athletes are told to drink for thirst during
exercise the incidence of EAH becomes negligible as
described in races held in South Africa and New Zealand.
In Ironman triathletes, large changes in body weight during
a triathlon were not associated with a greater prevalence of
medical complications or higher rectal temperatures but
were associated with higher serum [Na?] (Sharwood et al.
2004). In another study on Ironman triathletes, there was a
significant and positive correlation between serum [Na?]
and body weight change during the race: the greater the
body weight loss, the higher the serum [Na?] (Speedy et al.
1997b). An inverse relationship between post-race serum
[Na?] and change in body weight was observed in a further
study on Ironman triathletes (Speedy et al. 1997a). This
finding has been confirmed in laboratory studies (Noakes
2011).
An increase in body mass during endurance perfor-
mance might also be due to a development of oedema.
Williams et al. (1997) and Milledge et al. (1982) investi-
gated the effect of a 5–7 days hill walk, including the
post-exercise days, on fluid homeostasis. During their
investigation, the athletes were allowed to drink water
ad libitum. Williams et al. (1997), as well as Milledge et al.
(1982) described a positive water balance with a net
movement of fluid from the intracellular to the extracellular
space and, therefore, an expansion of the extracellular
space. Furthermore, they found that the packed cell volume
concentrated, indicating a decrease of the volume of the
vascular compartment. The expansion of the extracellular
volume was supposed to lead an increase in leg volume
(Milledge et al. 1982) and visible facial and ankle oedemas
might appear (Williams et al. 1997).
The development of oedemas after an ultra-endurance
performance such as a Triple Iron ultra-triathlon was also
recently described in a case report by Knechtle et al.
(2009a). These authors presumed that oedemas developed
in the skeletal muscle. The oedemas of the lower limbs
were clinically visible starting on day 2 post-race and
disappearing on day 6 post-race. Different mechanism
apart from fluid overload could lead to a retention in total
body water in ultra-endurance athletes such as protein
catabolism with the development of hypoproteinemic
oedemas (Lehmann et al. 1995), an increased protein
synthesis leading to increased plasma volume (Maughan
et al. 1985; Mischler et al. 2003), an increased [Na?]
retention (Fellmann et al. 1999) due to an increased activity
of aldosterone (Wade et al. 1981) or dehydration and an
impaired renal function due to skeletal muscle damage
(Uberoi et al. 1991).
The aim of the present study was to investigate a
potential association between both fluid and electrolyte
intake and the formation of peripheral oedemas leading to
an increase in limb volumes. Since a long race duration
(Almond et al. 2005; Chorley et al. 2007; Hew et al. 2003;
Noakes et al. 1985) and an increased availability of bev-
erages (Hew-Butler et al. 2005; Speedy et al. 2000b) are
described to increase the risk for fluid overload, we
investigated the development of peripheral oedemas in a
100-km ultra-marathoners. In these races, running speed is
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usually low (Knechtle et al. 2009b, 2010b, c, 2011c) and
the athletes can ingest fluids at several aid stations as well
as being provided by their support crews (Knechtle et al.
2009b, 2010b). We hypothesised that (i) the increased
availability of fluids would lead to fluid overload, thus
leading to an increased prevalence of EAH and (ii) that an
increased fluid intake during a race would lead to oedemas
of the extremities with an increase in limb volumes.
Methods
Subjects
The organiser of the ‘100-km Lauf Biel’ (http://www.
100km.ch) in Biel, Switzerland, contacted all participants of
the 2010 race 3 months before the start via a separate
newsletter and informed them about the planned investiga-
tion. Fifty-six recreational male ultra-runners volunteered to
participate in the study, 50 participants finished the race
successfully within the time limit of 21 h. The characteristics
of both their anthropometry and training are represented in
Table 1. The study was approved by the Institutional Review
Board for the Use of Human Subjects of the Canton of
Zurich, Switzerland, and all athletes gave their informed
written consent. The ‘100-km Lauf Biel’ has a long tradition
in Switzerland (Knechtle et al. 2009b, 2010b, c, 2011b, c).
The race has no sponsor for sports nutrition and the race
director gives no special advices regarding hydration strat-
egy for the race (http://www.100km.ch).
The race
The race took place on June 11, 2010. The athletes started
the 100-km road course ultra-marathon at 10:00 p.m.
During these 100 km, with a total change in altitude of
*645 m, the organiser provided a total of 17 aid stations
offering an abundant variety of food and beverages such as
hypotonic sports drinks, tea, soup, caffeinated drinks, water,
bananas, oranges, energy bars and bread. The athletes were
allowed to be supported by a cyclist to have additional food
and clothing, if necessary. The temperature at the start was
21.7C, dropping to 15.6C during the night and rising to
18.1C the next day. Humidity was 52% at the start, rising
to 62% during the night and to 69% the next day.
Measurements and calculations
On June 11, 2010 between 05:00 p.m. and 10.00 p.m., the
pre-race measurements were performed. Body mass was
measured using a commercial scale (Beurer BF 15, Beurer
GmbH, Ulm, Germany) to the nearest 0.1 kg after voiding
of the urinary bladder. Urine samples were collected and
venous blood samples were drawn. Two Sarstedt S-Mono-
vettes (serum gel, 7.5 ml) for chemical and one Sarstedt
S-Monovette (EDTA, 2.7 ml) (Sarstedt, Nu¨mbrecht) for
heamatological analysis were drawn. Monovettes for serum
and plasma were centrifuged at 3,000g for 10 min at 4C.
Plasma was collected and stored on ice. Urine was collected
in Sarstedt monovettes for urine (10 ml). Blood and urine
samples were transported immediately after collection to
the laboratory and were analysed within 6 h.
In the venous blood samples, haemoglobin, haematocrit,
serum sodium concentration ([Na?]), serum potassium
concentration ([K?]), serum creatinine concentration,
serum urea concentration, and serum osmolality were
measured. Haematologic parameters were determined
using ADVIA 120 (Siemens Healthcare Diagnostics,
Deerfield, IL, USA). Serum parameters were measured
using COBAS INTEGRA 800 (Roche, Mannheim, Ger-
many). Osmolality of serum and urine samples was deter-
mined using Fiske Modell 210 Mikro-Osmometer (IG
Instrumenten-Gesellschaft AG, Zurich, Switzerland).
Serum aldosterone concentration was measured using RIA
(Radio Immuno Assay) with Gamma-Counter 1277 (DRG
Instruments GmbH, Germany). Serum copeptin concen-
tration was analysed using TRACE (Time Resolved
Amplified Kryptat Emssion) with Kryptor (BRAHMS
GmbH, Germany). In the urine samples, creatinine, urea,
[Na?], [K?], urine specific gravity and urine osmolality
were determined. Urine specific gravity was analysed using
Clinitek Atlas Automated Urine Chemistry Analyzer
(Siemens Healthcare Diagnostics, Deerfield, IL, USA).
Creatinine and urea were measured using COBAS INTE-
GRA 800. Electrolytes were determined using ISE IL 943
Flame Photometer (GMI, Inc., Ramsey, MN, USA).
We expressed the urine concentrations as fractional
excretions. This applied to the following parameters:
Table 1 Characteristics of the subjects (n = 50)
n Mean CI 95%
Age (years) 50 47.8 (45.4; 50.3)
Body height (m) 50 1.79 (1.77; 1.81)
Body mass (kg) 50 74.9 (72.2; 77.7)
Body mass index (kg/m2) 50 23.3 (22.6; 23.9)
Experience in endurance sports (years) 50 11.8 (9.6; 14.1)
Training volume (h/week) 50 8.6 (5.6; 11.7)
Training volume (km/week) 50 66.5 (58.7; 74.4)
Training speed (km/h) 50 10.7 (10.3; 11.1)
Marathons finished (number) 50 33 (17.4; 48.7)
100 km races finished (number) 50 3.9 (2.4; 5.4)
Personal best marathon time (h:min) 48 03:31 (03:22; 03:40)
Personal best 100 km time (h:min) 35 11:22 (10:41; 12:03)
Results are presented as mean and 95% CI
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sodium, potassium, urea, and osmolality. We used the
general formula: fractional excretion of parameter =
[(parameterurine 9 creatinineserum)/(parameterserum 9 cre-
atinineurine)] 9 100 following Espinel (1976). Transtubular
potassium gradient was calculated using the equation: trans-
tubular potassium gradient = (potassiumurine 9 osmolal-
ityserum)/(potassiumserum 9 osmolalityurine) according to
West et al. (1986). Percentile change in plasma volume was
determined following Strauss et al. (1951).
The volume and the changes of volume in the arm and
lower leg were measured using the principle of plethys-
mography. We constructed a vessel using Plexiglas with
the internal dimensions of 386 mm length and 234 mm
width. These dimensions were chosen so that any foot size
of a male runner would fit in the vessel. The vessel was
then filled to 450 mm with plain water and the limb was
immersed. For the lower limb, the upper limit of the water
was at the middle of the knee; for the upper limb, the upper
limit of the water was at the armpit after immersion. The
water level was then measured to the nearest 1 mm and the
corresponding volume calculated using the length, width
and height in millimetres of the displaced water and
defined as the volume of the arm and lower leg, respec-
tively. Cubic millimetres were then converted to litres.
The thickness of subcutaneous adipose tissue was
measured at six sites to the nearest 0.1 mm using a LIP-
OMETER as described by Ju¨rima¨e et al. (2007). In order
to detect an increase in the thickness of the subcutaneous
adipose tissue due to a clinically visible or palpable
oedema in the face and limbs, the thickness of subcuta-
neous adipose tissue at the right side of the body at arcus
zygomaticus, the middle of os metacarpale III, at the
margo medialis tibiae, one handbreadth above malleolus
medialis, directly at malleolus medialis and at os cunei-
forme mediale was measured. The athletes were asked for
their subjective feelings regarding the swelling of their
hands and feet using a subjective 0–10 scale, where 0 was
defined as ‘I feel no swelling in hands or feet’ and 10 as ‘I
feel an extreme swelling in hands and feet’. Between 0 and
10, no other labels beside the extremes were given.
Immediately after arrival at the finish line, the identical
measurements were repeated. Between the pre-race and
post-race measurements, the athletes recorded their intake
of food and drinks using a prepared paper and pencil. At
each aid station they noted both the kind and the amount of
ingested food and fluids. At these aid stations, liquids and
food were prepared in a standardised manner, i.e., bever-
ages and food were provided in standardised size portions.
The drinking cups were filled to 0.2 L; the energy bars and
the fruits were halved. The athletes also recorded addi-
tional food and fluid intake provided by their support crew,
as well as their intake of salt tablets and other supplements.
The compositions of fluids and solid food were estimated
using a food table (Kirchhoff 2002). The day before the
race, during the race and the 3 days after the race, the
athletes recorded their urinary output using a graduated jug
to the nearest 0.1 L.
Statistical analysis
Data are presented as mean values and 95% confidence
interval (CI). Pre- and post-race results were compared
using paired t test. Pearson correlation analysis was used to
check for associations between the measured and calcu-
lated parameters. Statistical significance was accepted with
p \ 0.05 (two-sided hypothesis).
Results
Fifty of the 56 subjects finished the race within 12:15
(11:51; 12:47) h:min, running at a mean speed of 8.4 (8.0;
8.7) km/h. Their training and pre-race experience is rep-
resented in Table 1. The weekly running kilometres
(r = -0.28, p = 0.047), the speed in running during
training (r = -0.58, p \ 0.0001) and the personal best
marathon time (r = 0.61, p \ 0.0001) were related to the
100-km race time.
Table 2 shows the pre- and post-race measurements and
their changes. Body mass decreased by 1.9 kg (2.5%)
(p \ 0.0001). The volume in both the lower leg and the
arm showed no changes. In detail: in 19 runners arm the
volume increased, in 20 runners the volume showed no
change and in 11 runners arm the volume decreased. The
leg volume increased in 11 runners, remained stable in 13
runners, and decreased in 26 runners. The thickness of
subcutaneous adipose tissue increased at os metacarpale III
(p \ 0.0001), at malleolus medialis (p \ 0.001) and at os
cuneiforme mediale (p = 0.0332). The subjective feeling
of swelling increased for both the hands (p = 0.0002) and
the feet (p \ 0.0001).
Serum copeptin and aldosterone concentrations
increased (p \ 0.0001). Haemoglobin and haematocrit
remained unchanged, calculated plasma volume increased
by 1.0 (7.8)% (p [ 0.05). Serum osmolality increased by
1.9% (p \ 0.0001). Serum [Na?] increased by 1.6%
(p \ 0.0001), serum [K?] remained unchanged. Serum
urea concentration increased (p \ 0.0001). In 2 of the 50
successful finishers, serum [Na?] was both pre- and post-
race \135 mmol/L. In one subject, serum [Na?] dropped
from 133 mmol/L pre-race to 132 mmol/L post-race; in
the other subject, serum [Na?] increased from
131 mmol/L pre-race to 133 mmol/L post-race. The
change in body mass was significantly and negatively
related to both post-race serum [Na?] and running speed
(see Fig. 1).
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Fractional sodium excretion decreased, fractional
potassium excretion increased, fractional urea excretion
decreased, fractional osmolar excretion decreased and
transtubular potassium gradient increased (p \ 0.001).The
athletes consumed a total of 7.3 (6.6; 7.9) L of fluids during
the race, equal to 0.58 (0.53; 0.63) L/h. Expressed as a rate,
the athletes consumed 7.9 (6.4; 9.4) ml kg-1 h-1.
Regarding the intake of electrolytes, they ingested 7.1 (5.6;
8.6) mg of sodium h-1 kg-1 and 2.4 (2.1; 2.8) mg of
potassium h-1 kg-1. Sodium intake was neither related to
post-race serum [Na?] nor to the change in serum [Na?]
(p [ 0.05). Sodium intake showed no association with both
the change in lower leg volume (r = 0.10, p = 0.49) and
the change in arm volume (r = 0.24, p = 0.088). Energy
intake was 3.2 (2.6; 3.9) kcal h-1 kg-1.
Fluid intake was not associated with post-race serum
copeptin concentration, or the change in serum copeptin
concentration (p [ 0.05). Also, fluid intake correlated
neither to post race serum aldosterone concentration nor to
the change in serum aldosterone concentration (p [ 0.05).
The hourly fluid intake was significantly and positively
related to the running speed (see Fig. 1) with faster athletes
drinking more fluids while running. Fluid intake was sig-
nificantly and negatively related to the post-race serum
[Na?] (see Fig. 1) and significantly and negatively to the
change in serum [Na?] (r = -0.38, p = 0.0072).
Although the volumes in arm and lower leg showed no
changes during the race, total fluid intake during the race
was related to the change in both the arm and the lower leg
volume (see Fig. 2). Running speed was associated with
the changes in both arm volume lower leg volume (see
Fig. 2). Table 3 shows the relationship between fluid intake
and the changes in the thickness of subcutaneous adipose
tissue. The changes in the thicknesses of subcutaneous
adipose tissue at mallelous medialis and at os cuneiforme
mediale were not associated with the changes in lower leg
volume; the changes in the thicknesses of subcutaneous
adipose tissue at the middle of os metacarpale III also
showed no relationship with the changes in arm volume
(p [ 0.05).
The change in plasma volume was associated with total
fluid intake (r = 0.30, p = 0.0357), the changes in serum
Table 2 Results of the physical, haematological and urinary parameters before and after the race
Pre-race* Post-race* Percental change* p value**
Body mass (kg) 74.9 (72.2; 77.7) 73.0 (70.3; 75.7) -2.5 (-3.1; -2.1) \0.0001
Volume of the lower leg (L) 2.36 (2.25; 2.47) 2.38 (2.26; 2.49) 0.86 (-1.85; 3.58) 0.57
Volume of the arm (L) 4.08 (3.94; 4.23) 4.05 (3.89; 4.20) -0.65 (-3.21; 1.96) 0.45
Thickness subcutaneous fat at arcus zygomaticus (mm) 3.20 (2.84; 3.55) 3.14 (2.79; 3.49) 2.58 (-7.74;12.91) 0.63
Thickness subcutaneous fat at os metacarpale III (mm) 2.23 (1.84; 2.61) 4.38 (3.80; 4.96) 165.58 (99.34; 231.82) \0.0001
Thickness subcutaneous fat at margo medialis tibiae (mm) 3.27 (2.85; 3.68) 3.59 (3.29; 3.89) 24.45 (10.01; 40.89) 0.07
Thickness subcutaneous fat at malleolus medialis (mm) 2.10 (1.86; 2.34) 3.30 (2.94; 3.66) 80.53 (50.56; 110.51) \0.0001
Thickness subcutaneous fat at os cuneiforme mediale (mm) 1.75 (1.61; 1.88) 2.03 (1.79; 2.27) 23.28 (4.57; 41.99) 0.03
Subjective feeling of swelling of the hands 1.0 (0.6; 1.4) 2.9 (2.0; 3.8) 0.0002
Subjective feeling of swelling of the feet 0.9 (0.5; 1.3) 2.8 (2.0; 3.6) \0.0001
Plasma copeptin concentration (pmol/L) 6.4 (5.5; 7.4) 75.0 (50.4; 99.6) 1,212 (795; 1,628) \0.0001
Plasma aldosterone concentration (ng/L) 90 (79; 102) 424 (351; 496) 454 (333; 575) \0.0001
Haemoglobin (g/dl) 14.5 (14.3; 14.8) 14.5 (14.2; 14.8) -0.4 (-1.6; 0.9) 0.51
Haematocrit (%) 43.5 (42.7; 44.2) 43.3 (42.5; 44.2) 0.3 (-1.6; 1.0) 0.57
Serum sodium concentration (mmol/L) 136.6 (135.4; 136.7) 138.2 (137.6; 138.9) 1.6 (1.0; 2.2) \0.0001
Serum potassium concentration (mmol/L) 4.1 (4.0; 4.2) 4.3 (4.2; 4.4) 3.9 (0.1; 7.7) 0.07
Serum glucose concentration (mmol/L) 5.3 (5.0; 5.6) 5.4 (5.1; 5.8) 7.1 (-1.8; 16.1) 0.47
Serum creatinine concentration (lmol/L) 77.8 (74.5; 81.1) 100.4 (93.3; 107.5) 30.1 (21.1; 39.2) \0.0001
Serum urea concentration (mmol/L) 5.7 (5.4; 6.0) 9.1 (8.4; 9.8) 61.5 (49.5; 73.6) \0.0001
Serum osmolality (mosmol/kg H2O) 296.4 (295.1; 297.6) 302.0 (299.9; 304.1) 1.9 (1.2; 2.7) \0.0001
Urinary specific gravity (g/ml) 1.017 (1.015; 1.019) 1.026 (1.015; 1.028) 0.93 (0.72; 1.1) \0.0001
Urinary osmolality (mosmol/kg H2O) 672.0 (531.0; 773.0) 893.5 (831.0; 955.0) 157.5 (86.0; 224.0) \0.0001
Fractional potassium excretion (%) 0.114 (0.098; 0.129) 0.191 (0.168; 0.214) 100 (64; 136) \0.0001
Fractional urea excretion (%) 52.7 (49.1; 56.4) 31.0 (26.8; 35.1) -39.0 (-47.7; -30.2) \0.0001
Transtubular potassium gradient (ratio) 28.3 (21.8; 34.8) 99.7 (84.9; 114.6) 828 (378; 1,278) \0.0001
* n = 50, mean value, CI 95%, ** by paired t test
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osmolality (r = -0.32, p = 0.0241), the changes in serum
aldosterone concentration (r = -0.40, p = 0.0037), the
changes in lower leg volume and the changes in arm vol-
ume (see Table 3), but showed no association with the
changes in serum copeptin concentration, fractional urea
excretion, sodium intake, or the changes in the thicknesses
of subcutaneous fat at os metacarpale III, at malleolus
medialis or at os cuneiforme mediale (p [ 0.05). The
increase in serum osmolality was highly significantly
associated with the increase in both serum urea (r = 0.71,
p \ 0.0001) and serum [Na?] (r = 0.51, p \ 0.0001). For
urine, the increase in osmolality was highly significantly
related to the increase in urine urea (r = 0.77, p \ 0.0001)
and to the decrease in urine [Na?] (r = 0.57, p \ 0.0001).
There was a strong and positive relationship between the
changes in serum osmolality and serum copeptin concen-
tration (r = 0.61, p \ 0.001) and between serum copeptin
concentration and urine osmolality (r = 0.38, p \ 0.001).
The changes in serum copeptin concentration were related
to the changes in serum [Na?] (r = 0.36, p = 0.01); post-
race serum copeptin concentration was not associated with
post-race serum [Na?]. Post-race serum copeptin concen-
tration and the change in serum copeptin concentration
were not related to running speed. The changes in serum
aldosterone concentration were highly significantly and
positively associated with the post-race changes in the
transtubular potassium gradient (r = 0.37, p = 0.0078).
Post-race serum aldosterone concentration (r = 0.36,
p = 0.0110) and the change in serum aldosterone con-
centration (r = 0.38, p = 0.0065) were both significantly
and positively related to running speed. Post-race serum
aldosterone concentration was not related to post-race
serum [Na?].
The athletes recorded 5.6 (4.5; 6.6) micturitions and
voided 1.5 (1.2; 1.8) L of urine during the race, equal to 1.6
(1.3) ml h-1 kg-1. Urine excretion increased significantly
during the race, as compared to pre-race, and was reduced
post-race, reaching pre-race levels only on day 3 after the
race. The changes in serum copeptin concentration were
neither related to the number of micturitions nor to urine
excretion during the race (p [ 0.05). The change in the
subjective feeling of swelling in the hands was not asso-
ciated with the change in the thickness of subcutaneous fat
at os metacarpale III; or the feet at malleolus medialis, or
at os cuneiforme mediale (p [ 0.05). Also, the change in
the subjective feeling of swelling in the hands showed
neither an association with the change in arm volume or
with the change in leg volume (p [ 0.05).
Discussion
A main finding of this study was that total fluid intake
during the race was positively related to the changes in
Fig. 1 The change in body
mass was significantly and
negatively related to post-race
serum [Na?] (r = -0.42,
p = 0.0022) and to running
speed (r = -0.31, p = 0.027).
Hourly fluid intake was
significantly and negatively
related to post-race serum [Na?]
(r = -0.34, p = 0.0145), and
significantly and positively to
running speed (r = 0.33,
p = 0.0182) (n = 50)
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both arm and lower leg volume where an increased fluid
intake was associated with an increase in limb volumes.
The changes in limb volumes were related to running speed
where faster runners showed a decrease in limb volumes.
Also, fluid intake was related to running speed where faster
runners were drinking more. Obviously, faster runners
were drinking more without the risk to develop peripheral
oedemas. In addition, faster runners were drinking at a
faster rate during the race as compared to slower runners
and slower runners finished the race with lower levels of
dehydration. Although faster runners were drinking more
each hour, they were losing more body mass during the
race presumably due to more sweating but they were still
drinking appropriately at a relatively lesser rate than were
the slower runners. While the changes in limb volumes
were related to both total fluid intake and running speed but
not to sodium intake, changes in fluid and electrolyte
regulating hormones and renal function, the relative fluid
overload in slower runners seems to be the most likely
reason to develop peripheral oedemas.
Correlation of fluid and electrolyte intake
with performance
The changes in volumes of both the arm and the lower leg
correlated to total fluid intake during the race, but not to
sodium intake (see Fig. 2). These athletes showed a vari-
ation of total fluid intake between 2.7 and 10.6 L during the
race with a mean fluid intake of 7.3 L is equal to*0.58 L/h.
Running speed was significantly and negatively associ-
ated with the changes in both arm and lower leg volume
(see Fig. 2). These findings allows us to support the
Fig. 2 Total fluid intake was significantly and positively associated
with both the change in arm volume (r = 0.46, p = 0.0007) and the
change in lower leg volume (r = 0.29, p = 0.043). Running speed
correlated significantly and negatively to both the change in arm
volume (r = -0.37, p = 0.0091) and the change in lower leg volume
(r = -0.47, p = 0.0005) (n = 50)
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hypothesis of race duration as a risk factor for fluid over-
load, described by Chorley et al. (2007) for marathoners
and by Noakes et al. (1988, 1990) for ultra-marathoners
and possibly resulting in oedemas. The runners overdrink
because they believe that if they do not they may die of
‘dehydration’ or that their performance will be impaired
(Noakes 2011). Chorley et al. (2007) concluded that slower
runners were more likely to overconsume fluids, aug-
mented by their exposure to more environmental heat stress
during the warmer part of the race. Recently, the same
correlation between fluid intake and mean running speed
was also shown by Knechtle et al. (2010a) in a 24 h ultra-
marathon. In the present study, we found an increase in
plasma volume which was associated with total fluid
intake. As overhydration, or excessive fluid consumption,
during activity is the major risk factor for EAH (Almond
et al. 2005; Hew et al. 2003; Irving et al. 1991; Noakes
et al. 1985; Noakes 2011), we assumed, therefore, that fluid
intake was responsible for the development of oedemas.
Redistribution of the volume
The volume of both the lower leg and the arm showed no
changes whereas the thickness of adipose subcutaneous
tissue at os metacarpale III, malleolus medialis, and os
cuneiforme mediale increased using the LIPOMETER.
We presume that the volume in the arm and lower leg
showed no changes during the race because there was a
redistribution of the limb volume limited to dorsum mani
and dorsum pedis and not involving the whole limb. We
found no relationship between the significant changes in
the thickness of subcutaneous adipose tissue on dorsum
mani and at dorsum pedis with the non-significant changes
in the corresponding limb volumes. As the entire extrem-
ities were measured using plethysmography, we were not
able to differentiate between arm and hand or between
lower leg and foot, respectively.
Trauma to the feet from repetitive landing could rea-
sonably result in injury and swelling of the feet. A further
aspect is the centripetal force in the upper extremities while
running and the gravitational force for the lower extremi-
ties. Another mechanism for developing oedemas, specifi-
cally the absence of oedemas in feet immediately after the
race, but the development of them shortly afterwards which
has also been described by Knechtle et al. (2009b), could
be the fact that the athletes were wearing running shoes
compressing their feet. Due to the compression, the
development of oedemas of the feet during the race was
prevented. When the shoes were removed, the fluid in the
adipose subcutaneous tissue might be redistributed. After
removing the shoes, the compression decreased and a
redistribution of fluid from the lower leg into the foot,
especially into the subcutaneous adipose tissue, could
occur, leading to oedemas in the feet. Therefore, the vol-
ume of the lower leg showed no changes while the thick-
ness of adipose subcutaneous tissue, measured at malleolus
medialis and at os cuneiforme mediale, increased. The
assumption of a redistribution of fluid into the subcutane-
ous adipose tissue of the hands and feet could be supported
by the finding that we could not document any changes in
thickness of subcutaneous adipose tissue at arcus zygom-
aticus in the face and at margo medialis tibiae at the lower
leg above the foot.
Other potential pathophysiological mechanisms leading
to peripheral oedemas
A slower race time seems to be associated with a change in
both arm and lower leg volume. This might be due to the
fact that these athletes were exposed for a longer time to
running in an upright position, where the consequent
gravitational force possibly led to more oedemas in both
the hands and the feet. Apart from fluid overload, however,
different other mechanisms could lead to a retention of
total body water, and therefore, to an increase in limb
volumes and a development of peripheral oedemas, such as
protein catabolism with the development of hypoproteine-
mic oedemas (Lehmann et al. 1995), an increased protein
synthesis leading to increased plasma volume (Maughan
et al. 1985, Mischler et al. 2003), [Na?] retention (Fell-
mann et al. 1999) due to an increased activity of aldoste-
rone (Wade et al. 1981) or dehydration and impaired renal
function due to skeletal muscle damage (Uberoi et al.
1991).
Milledge et al. (1982) described the activation of the
renin-angiotensin-system and plasma aldosterone as a
possible reason for the expansion in plasma volume and
water retention possibly leading to oedemas. An increase in
plasma volume due to sodium retention was mentioned by
Fellmann et al. (1999). The change in serum [Na?] in the
present subjects showed a correlation with the change in
serum copeptin concentration, a co-secreted cleavage
product of vasopressin, but not with serum aldosterone
concentration. In the presence of an increased blood
osmolality, vasopressin is released (Hew-Butler 2010),
explaining the increase in serum copeptin concentration
during the race. Vasopressin reduces renal free water
excretion by activating arginine vasopressin receptor 2
(AVPR2) in the collecting tubules and, as a result, urine
osmolality also increases (Hew-Butler 2010; Verbalis
2007). Vasopressin should be suppressed in case of hypo-
natremia/hypervolemia (Hew-Butler et al. 2008). A fluid
overload could be due to water retention caused by an
inappropriate manner of vasopressin release (Hew-Butler
2010; Hew-Butler et al. 2008). In the present study, we
found a positive relationship between serum copeptin
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concentration and urine osmolality, assuming that there
was a physiological secretion of vasopressin. The changes
in serum copeptin concentration were related to the chan-
ges in serum [Na?]. In addition, post-race serum [Na?] was
neither related to post-race serum copeptin nor to post-race
serum aldosterone concentration. We assume that post-race
serum [Na?] was not regulated due to hormones such as
aldosterone and copeptin.
The intake of non-steroidal anti-inflammatory drugs
(NSAIDs) is also a risk factor for EAH (Davis et al. 2001).
NSAIDs use is common among athletes, being used by
50–60% (Hew et al. 2003). These drugs are known to
increase the potential effects of vasopressin by inhibiting
renal prostaglandin synthesis via the Cyclooxygenase-2
(COX-2) isoform of cyclo-oxygenase (Breyer et al. 1990;
Hebert et al. 1990). NSAIDs decrease the glomerular fil-
tration rate when given to those with effective volume
depletion, such as exercising endurance athletes (Patrono
and Dunn 1987). The urine-diluting capacity of the kidney
may be impaired by these effects. These theoretical con-
siderations, such as NSAIDs as a risk factor for EAH,
remain controversial as, for example, Almond et al. (2005)
found no association between the uses of NSAIDs with the
development of EAH in runners in the 2002 ‘Boston
Marathon’. In contrast to Almond et al. (2005); Wharam
et al. (2006) demonstrated a significant association.
Therefore, the role of NSAIDs in the development of EAH
remains controversial but in some runners it is a potential
risk factor for EAH. Unfortunately, these athletes were not
asked about their consumption of NSAIDs.
There are medical risk factors in the general population
that may also play a role in developing EAH and therefore
leading to water retention. Rosner (2004) described an
altered renal water excretory capacity potentially impaired
by drugs such as serotonin-specific reuptake inhibitors
(SSRIs) and diuretics as a risk factor for EAH. Medications
such as selective serotonin re-uptake inhibitors or thiazide
diuretics, associated with hyponatremia in non-athletes, but
not known to increase the development of EAH, may be
possibly important clues to the pathogenesis of EAH
(Rosner and Kirven 2007). Altered renal function caused
by intrinsic renal disease, a risk factor for the development
of hyponatremia in the general population that may also
play a role in EAH was described by Ayus et al. (1982).
Hyponatremia could lead to overhydration due to a vaso-
pressin release. Schwartz et al. (1957) described the syn-
drome of inappropriate antidiuretic hormone hypersecretion
(SIAHD) as another risk factor. In SIADH, the release of
vasopressin is not inhibited by a reduction in plasma
osmolality. Therefore, overdrinking causes hyponatremia if
there is also SIADH present (Noakes et al. 2005).
In the present study, urine excretion significantly
increased during the race as compared to pre-race, andT
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became reduced post-race, reaching pre-race levels only on
day 3 after the race. During the race, the athletes voided
*120 ml of urine per hour. When the athletes voided more
than 500 ml in 24 h then their fluid intake during the race
was excessive by that additional amount since obligatory
urinary losses are about 500 ml per 24 h. The kidney
needed about 3 days post-race to recover and to function as
before. This fact has already been described by Knechtle
et al. (2009a). For urine, the increase in osmolality,
matching the fact that athletes urinated less frequently, was
significantly related to the increase in urea and to the
decrease in sodium. An overhydration could possibly lead
to oedemas in the extremities. Therefore, we assume that
an altered renal function could also be a part of the
mechanism leading to peripheral oedemas.
Prevalence of exercise-associated hyponatremia
A further finding was that no athlete suffered EAH. Except
for two successful finishers, all athletes finished with an
increased serum [Na?]. The remaining two athletes showed
an over-hydration already at the start with a serum [Na?]
pre- as well as post-race \135 mmol/L. Regarding the
association between the change in body mass and post-race
serum [Na?], we found a significant and negative corre-
lation (see Fig. 1). Serum [Na?] increased by 1.6% and
body mass decreased by 1.9 kg. This negative correlation
between the change in body mass and post-race serum
[Na?] corresponds to results in former studies, where
athletes with less weight loss (or weight gain) showed
lower serum [Na?] (Mettler et al. 2008; Noakes et al. 2005;
Sharwood et al. 2004; Speedy et al. 1997a, b, 1999).
Furthermore, we found a significant and negative cor-
relation between post-race serum [Na?] and fluid intake
(see Fig. 1); athletes who drank less during the race
showed higher post-race serum [Na?]. These findings
support the existing data in the studies of Noakes et al.
(1985, 2011); Irving et al. (1991) as well as the different
studies of Speedy et al. (1997a, 1999, 2000a, b, c, 2001) in
the pathogenesis of EAH. Fluid overload, as a consequence
of excessive drinking, was described several times as the
main risk factor in the pathogenesis of EAH (Almond et al.
2005; Hew et al. 2003; Noakes et al. 1985). Therefore,
athletes are recommended by the ‘Position Statement’ of
the ‘International Marathon Medical Directors Association’
(Noakes 2003) to drink ad libitum between 0.4 and 0.8 L/h
during a race, which was followed by our athletes con-
suming *0.58 L/h on average despite the high frequency
of refreshment stations during this race.
Additionally, this study supports the important findings
in the reports of Hew-Butler et al. (2006); Speedy et al.
(2002) and Noakes (2011) describing no correlation
between sodium intake, post-race serum [Na?] and the
change in serum [Na?]. While Hew-Butler et al. (2006)
investigated the change in serum [Na?] with sodium or
placebo supplementation as compared to a group without
supplementation and normal eating and drinking habits,
Speedy et al. (2002) investigated a group using only salt
supplementation. Hew-Butler et al. (2006) reported no
significant differences in serum [Na?] in their different
groups and Speedy et al. (2002) described no correlations
with salt supply and the change in serum [Na?]. Almond
et al. (2005) also showed that sodium ingestion was not
protective against EAH in runners in the 2002 ‘Boston
Marathon’. Finally, Noakes (2011) stated clearly that EAH
during an endurance exercise cannot be prevented by
ingestion of a sodium-containing sports drink.
Are the applied methods reliable?
Lastly, we could also explain the findings of the disparate
results in limb volumes and thickness of subcutaneous
adipose tissue of the extremities as a potential limitation of
the applied method of plethysmography while measuring
the volumes of both the lower leg and arm. The method of
measuring limb volume using plethysmography is similar
to the method chosen by Lund-Johansen et al. (2003)
measuring the displaced water by weighing. Lund-Johan-
sen et al. (2003) concluded that water displacement volu-
metry was a sensitive method for the measurement of leg
volume. Therefore, we assumed that measuring changes in
limb volumes using plethysmography was an accurate
method for the quantification of oedemas of the whole
limb. The thickness of subcutaneous adipose tissue was
measured using a LIPOMETER as described by Ju¨rima¨e
et al. (2007). The LIPOMETER is a non-invasive
examination using infrared. Different investigators have
already used the LIPOMETER in their studies. Tafeit
et al. (2009) described the LIPOMETER as a non-inva-
sive, quick, precise and safe measurement of subcutaneous
adipose tissue at any site in the human body. Furthermore,
Mo¨ller et al. (2000) used the LIPOMETER in their study,
and documented that the technique allowed a precise
determination of the distribution of subcutaneous adipose
tissue at specified body sites. Therefore, we assume the
LIPOMETER as an accurate method for the identification
of the thickness of subcutaneous adipose tissue.
Limitations and implications for future research
directions
A limitation of this study might be the limited method of
measuring the extremities volume by using a plethysmog-
raphy, as mentioned above. By using the plethysmography
for the whole limb, we were not able to distinguish
between arm and hand or the lower leg and foot results,
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respectively. Technically, this approach would not measure
precisely the same limb length if there had been a change
in volume. A more appropriate approach for that would be
to measure the volume loss from a full container after the
limb has been inserted. In future studies, the volume in
hands and feet instead of arms and lower legs should be
measured using plethysmography to confirm our assump-
tions. Slight changes in the water distribution of the body
influencing the thickness of the dermis under various
physiological conditions have also been shown by Eisen-
beiss et al. (2001) by measuring thickness and echodensity
using high-frequency ultrasound. In future studies, the
effect of compression stockings on the development of
peripheral oedemas in ultra-marathoners might be investi-
gated (Kemmler et al. 2009). A further limitation may be
the fact that food and drink diaries were only recorded by
the runners. Experts experience has shown that an accurate
collection of such data can be very difficult (Rehrer et al.
2010). We measured a part of the fluid loss such as urine
excretion, but do not know sweat rate and would need to
estimate endogenous fluid production to complete a fluid
balance.
Conclusions
To summarise, a relationship between fluid intake and
changes in both arm and lower leg volumes was found. An
increase in both the lower leg and arm volume could be
demonstrated in athletes with an increased fluid intake. We
found no athlete developing EAH. Therefore, we con-
cluded that our athletes did not generally believe they need
to drink as much as possible during an exercise, rather they
were drinking only in response to their thirst. Since we
found no association between endocrine and renal param-
eters with the changes in limb volumes, fluid overload is
the likely mechanism leading to an increase in limb vol-
umes. For practical application, when an athlete drinks
more than he needs, that fluid will eventually end up in his
limbs. Due to the disparate findings of changes in limb
volumes using plethysmography and thickness of subcu-
taneous adipose tissue, the measurements of changes in
limb volumes should be restricted in future studies to hands
and feet.
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